A Study to Evaluate Peptamen in Obese Patients


About this study

The purpose of this study is to assess the effects of Peptamen Intense on body weight in tube-fed adults with obesity.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults, age ≥ 18 years old.
  • of Home Enteral Nutrition (HEN) patient receiving at least 90% of energy needs from enteral nutrition.
  • BMI > 30.
  • History of stroke.
  • Weight stable over the past month.

Exclusion Criteria: 

  • Diagnosis of cancer undergoing active treatment (chemotherapy, radiation, immunotherapy).
  • Life expectancy of less than 6 months.
  • Stage IV or higher kidney disease (GFR < 30).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Manpreet Mundi, M.D.

Open for enrollment

Contact information:

Osman Mohamed Elfadil M.B.B.S.

(507) 284-4080


More information


Publications are currently not available

Mayo Clinic Footer